4925 — Haba Laboratories Share Price
0.000.00%
Last trade - 00:00- ¥7bn
- ¥5bn
- ¥12bn
- 85
- 37
- 39
- 56
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.75 | ||
| Price to Tang. Book | 0.76 | ||
| Price to Free Cashflow | 17.66 | ||
| Price to Sales | 0.53 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -10.04% | ||
| Return on Equity | -10.78% | ||
| Operating Margin | -7.8% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ¥m | 18,369.64 | 14,307.71 | 12,908.86 | 12,038.05 | 12,324.21 | n/a | n/a | -8.54% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -35.06 | -85.47 | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
HABA LABORATORIES, INC. is principally engaged in the manufacture and sale of cosmetics and dietary supplements. The Company's main business consists of the research, development, manufacture and distribution of women's and men's cosmetics. The Company offers its products by wholesale distribution to department stores and through mail order services to general customers. It also handles wholesale distribution to retailers and wholesalers, as well as the sale of products at its own retail stores.
Directors
- Masayuki Koyanagi CHM (74)
- Noriko Koyanagi PRE (71)
- Noriyasu Komata CEX (57)
- Kazuyuki Umezu CEX (60)
- Akio Fujii MDR
- Chieko Hiromori OTH (59)
- Mitsuru Ohno OTH (42)
- Hiroki Shibata OTH (49)
- Toshinori Sugawara DRC (62)
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- May 21st, 1976
- Public Since
- June 11th, 2003
- No. of Shareholders
- 15,944
- No. of Employees
- 631
- Sector
- Personal & Household Products & Services
- Industry
- Consumer Defensives
- Exchange
- Tokyo Stock Exchange
- Shares in Issue
- 3,781,519
- Address
- 1-24-11, Kanda Suda-cho, CHIYODA-KU, 101-0041
- Web
- https://haba-lab.jp/
- Phone
- +81 352966250
- Auditors
- A & A Partners Audit
Upcoming Events for 4925
Similar to 4925
AB&Company Co
Tokyo Stock Exchange
Adjuvant Holdings Co
Tokyo Stock Exchange
AIAI
Tokyo Stock Exchange
ALMADO
Tokyo Stock Exchange
Aoba-BBT
Tokyo Stock Exchange
FAQ
What is the Haba Laboratories share price?
As of Today at 20:59 UTC, shares in Haba Laboratories are trading at ¥1,711. This share price information is delayed by 15 minutes.
How has the Haba Laboratories share price performed this year?
Shares in Haba Laboratories last closed at ¥1,711 and the price had moved by -15.26% over the past 365 days. In terms of relative price strength the Haba Laboratories share price has underperformed the Nikkei 225 Index by -10.69% over the past year.
What are the analyst and broker recommendations for Haba Laboratories?
There is no consensus recommendation for this security.
Find out moreWhat is the Haba Laboratories dividend yield?
The Haba Laboratories dividend yield is 2.34% based on the trailing twelve month period.
Does Haba Laboratories pay a dividend?
Last year, Haba Laboratories paid a total dividend of ¥40, and it currently has a trailing dividend yield of 2.34%.Looking ahead, the next dividend pay date is 2025-06-01.
When does Haba Laboratories next pay dividends?
We do not have data on when Haba Laboratories is to next pay dividends. The historic dividend yield on Haba Laboratories shares is currently 2.34%.
How do I buy Haba Laboratories shares?
To buy shares in Haba Laboratories you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Haba Laboratories?
As of the previous close price of ¥1,711, shares in Haba Laboratories had a market capitalisation of ¥7bn.
Where are Haba Laboratories shares listed?
Here are the trading details for Haba Laboratories:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 4925
What kind of share is Haba Laboratories?
Based on an overall assessment of its quality, value and momentum Haba Laboratories is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Haba Laboratories share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Haba Laboratories share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Haba Laboratories. Over the past six months, its share price has underperformed the Nikkei 225 Index by -3.14%.
As of the last closing price of ¥1,711, shares in Haba Laboratories were trading -6.25% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Haba Laboratories PE Ratio?
The Haba Laboratories PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at ¥1,711.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Haba Laboratories?
Haba Laboratories' management team is headed by:
- Masayuki Koyanagi - CHM
- Noriko Koyanagi - PRE
- Noriyasu Komata - CEX
- Kazuyuki Umezu - CEX
- Akio Fujii - MDR
- Chieko Hiromori - OTH
- Mitsuru Ohno - OTH
- Hiroki Shibata - OTH
- Toshinori Sugawara - DRC